ConductScience.org, home

Paper977253

Comparison of ocular prostaglandin synthesis inhibitors.

Podos SM and 1 other. Invest Ophthalmol, 1976. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. Comparison of ocular prostaglandin synthesis inhibitors. Papers, record 977253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/977253

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Comparison of ocular prostaglandin synthesis inhibitors.
PubMed
Journal
Invest Ophthalmol
PubMed
Year
1976
PubMed
Publication types
Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
3.77
iCite
Revised in PubMed
2006-11-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Podos SMS M
2Becker BB

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Eye ProteinsMajor topic
Prostaglandin AntagonistsMajor topic
ProstaglandinsMajor topic
Animals
Anti-Inflammatory Agents
Aqueous Humor
Arachidonic Acids
Dose-Response Relationship, Drug
Glaucoma
Intraocular Pressure
Rabbits

Source PubMed

Download CSV of topics

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
28063026Tierexperimentelle untersuchungen zur rolle von entzündungsmediatoren bei der hornhautneovaskularisation.Doc Ophthalmol1984https://conductscience.org/library/papers/28063026PubMed
10360304The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery.Trans Am Ophthalmol Soc1998https://conductscience.org/library/papers/10360304PubMed
7924852Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin.Doc Ophthalmol1994https://conductscience.org/library/papers/7924852PubMed
7736686Clinical pharmacokinetics of flurbiprofen and its enantiomers.Clin Pharmacokinet1995https://conductscience.org/library/papers/7736686PubMed
7227171The effect of indomethacin on the anterior segment of the eye after paracentesis.Doc Ophthalmol1981https://conductscience.org/library/papers/7227171PubMed
6763806Corneal reepithelialization and anti-inflammatory agents.Trans Am Ophthalmol Soc1982https://conductscience.org/library/papers/6763806PubMed
6662004Indomethacin eyedrops and the postoperative irritation after extracapsular cataract extraction combined with intraocular lens implantation.Doc Ophthalmol1983https://conductscience.org/library/papers/6662004PubMed
6546730The effect of YAG laser iridotomy on the blood aqueous barrier in the rabbit.Graefes Arch Clin Exp Ophthalmol1984https://conductscience.org/library/papers/6546730PubMed
6533296Ocular and systemic bioavailability of ophthalmic flurbiprofen.J Pharmacokinet Biopharm1984https://conductscience.org/library/papers/6533296PubMed
6336954Effect of indomethacin in preventing surgically induced miosis.Br J Ophthalmol1983https://conductscience.org/library/papers/6336954PubMed
4040006The effect of topically applied prostaglandin inhibitors on the laser-induced disruption of the blood aqueous barrier.Doc Ophthalmol1985https://conductscience.org/library/papers/4040006PubMed
2579877Effects of S-596 and carteolol, new beta-adrenergic blockers, and flurbiprofen on the human eye: a fluorophotometric study.Graefes Arch Clin Exp Ophthalmol1985https://conductscience.org/library/papers/2579877PubMed
1521802Topical indomethacin in the treatment of chronic cystoid macular edema.Graefes Arch Clin Exp Ophthalmol1992https://conductscience.org/library/papers/1521802PubMed
598275Prostaglandins and ocular inflammation.Doc Ophthalmol1977https://conductscience.org/library/papers/598275PubMed
391529Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases.Drugs1979https://conductscience.org/library/papers/391529PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/977253

GET https://conductscience.org/api/papers/v1/977253/authors